Cann Group Limited (ASX:CAN)
Australia · Delayed Price · Currency is AUD 0.0080
-0.0010 (-11.11%)
Jan 30, 2026, 3:58 PM AEST
Cann Group Company Description
Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe.
Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.
Cann Group Limited
| Country | Australia |
| Founded | 2014 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Jennifer Pilcher |
Contact Details
Address: 23 Greentek Court Mildura, VIC 3501 Australia | |
| Phone | 61 3 9095 7088 |
| Website | canngrouplimited.com |
Stock Details
| Ticker Symbol | CAN |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000CAN2 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jennifer Lee Pilcher AGIA, BBS, C.A. | Chief Executive Officer, MD and Executive Director |
| Steven Notaro BA, J.D. | Head of Legal and Regulatory Affairs and Company Secretary |